Cic edizioni internazionali
Functional Neurology

Add-on perampanel and aggressive behaviour in severe drug-resistant focal epilepsies

Article, 215 - 220
doi: 10.11138/FNeur/2017.32.4.215
Tag this article
Abstract
Enhanced HTML Full text PDF
This study aimed to investigate the incidence of aggressiveness in patients with severe drug-refractory focal epilepsy (DRE) who started perampanel (PER) as add-on treatment, and to identify possible predisposing factors.
Data on 49 consecutive patients with severe DRE who initiated PER were retrospectively collected. Twelve of the 49 patients experienced aggressiveness as adverse event related to PER treatment, one third of them on low (2-4 mg/day) PER dosages.
PER was discontinued in 10/12 patients because of aggressive behaviors. Aggressiveness could appear after several months or even more than one year of PER treatment. One third of patients with PER-related aggressiveness had intellectual disabilities and 5/12 patients took levetiracetam as a concomitant antiepileptic drug.
Our study suggests that the occurrence of aggressive behaviors in patients with severe DRE is not uncommon during PER treatment and that it may occur after months or even years of treatment with a stable dosage, requiring PER discontinuation in the great majority of patients.

Vol. XXXIII (No. 2) 2018 April/June

  1. Shorter acute care hospital stay, longer stay in post-acute care facilities
    Formisano R., Contrada M., Aloisi M.
    doi: 10.11138/FNeur/2018.33.2.065
  2. Understanding the pathophysiology of hyperglycemia-associated chorea-ballism: a systematic review of positron emission tomography findings
    Gómez Ochoa S. A., Espín Chico B.B.
    doi: 10.11138/FNeur/2018.33.2.067
  3. A review of 500 patients with acute stroke admitted to the University Hospital of Saudi Arabia. Similarities and differences compared with the published literature
    Zafar A.
    doi: 10.11138/FNeur/2018.33.2.073
  4. Direction-specific cortical response immediately after moving tactile stimuli in female humans
    Hiraoka K., Kento Y., Kiya H., Nozaki Y., Hayashi T.
    doi: 10.11138/FNeur/2018.33.2.081
  5. Impact of epilepsy after severe brain injury on safe resumption of driving: two-year follow-up
    Saviola D., De Tanti A., Delsoldato S., Chiari M., Inzaghi M.G., Baldari F.
    doi: 10.11138/FNeur/2018.33.2.091
  6. Epidemiological and clinical characteristics of 492 patients in a vegetative state in 29 Italian rehabilitation units. What about outcome?
    Avesani R., Dambruoso F., Scandola M., Formisano R., De Tanti A., Ferro S., Smania N., Roncari L., Rossato E.
    doi: 10.11138/FNeur/2018.33.2.097
  7. Laterality in Parkinson’s disease may predict motor and visual imagery abilities
    Lo Monaco M.R., Laudisio A., Fusco D., Vetrano D.L., Ricciardi D., Delle Donne V., Proietti F., Zuccalà G., Silveri M.C.
    doi: 10.11138/FNeur/2018.33.2.105
  8. Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study
    Baricich A., Cosenza L., Sandrini G., Paolucci S., Morone G., Santamato A., Cinone N., Peri E., Picelli A., Invernizzi M., Ferriero G.
    doi: 10.11138/FNeur/2018.33.2.113
  9. Musculoskeletal impairment and functional limitations in a patient affected by mutation in the laminin a-5 gene
    Liguori S., de Sire A., Moretti A., Sodano L., Sampaolo S., Gimigliano F., Iolascon G.
    doi: 10.11138/FNeur/2018.33.2.117
Last Viewed articles: la lista degli ultimi x visitati.
  1. Add-on perampanel and aggressive behaviour in severe drug-resistant focal epilepsies
    Juhl S., Rubboli G.
    doi: 10.11138/FNeur/2017.32.4.215
credits